Mixed Bag for ImmunoGen Inc.
Pipeline progressing but with some setbacks mixed in.
Illumina's Earnings Set Positive Tone for Biotech
What's behind Illumina's remarkable earnings beat, and what could it mean for biotech stocks?
10 Most Hated Companies in Healthcare
When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.
Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today
Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.
The 3 Best Stocks for Investing in Cholesterol Drugs
An aging population and rising prevalence of heart disease suggest that investing in the next generation of cholesterol drugs could prove to be profitable.